SEOUL, Jan 19 (Korea Bizwire) – The U.S. Food and Drug Administration (FDA) has released its draft guidance on biosimilar interchangeability, a move that will allow South Korean bio-pharmaceutical firm Celltrion Inc. to increase its presence in the U.S. market, company officials said Thursday. The FDA unveiled the guidance Tuesday (local time) that recommends that [...]
SEOUL, Jan. 18 (Korea Bizwire) – Biomedicine exports by South Korean pharmaceutical firms jumped more than 50 percent in 2016 from a year earlier to surpass the US$1 billion mark for the first time, data showed Wednesday. Outbound shipments of locally manufactured biomedicines such as vaccines and genetic recombination drugs stood at US$1.44 billion last [...]
SEOUL, March 26 (Korea Bizwire) — The market value of bio and health care shares listed on the South Korean stock markets surpassed 30 trillion won (US$27.22 billion) for the first time as investors pinned high hopes on their future growth, the bourse main operator Korea Exchange (KRX) said Thursday. The combined market cap of the [...]